pleuromutilins (Durata)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepleuromutilins (Durata)
Drug Alias Nameantibiotics (Durata)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionProtein synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDurata Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDurata Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A